Penumbra, Inc. (NYSE:PEN) Shares Purchased by Teacher Retirement System of Texas

Teacher Retirement System of Texas raised its position in shares of Penumbra, Inc. (NYSE:PEN - Free Report) by 36.8% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,773 shares of the company's stock after acquiring an additional 2,897 shares during the period. Teacher Retirement System of Texas' holdings in Penumbra were worth $2,881,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. First Horizon Advisors Inc. boosted its stake in shares of Penumbra by 404.8% during the first quarter. First Horizon Advisors Inc. now owns 106 shares of the company's stock valued at $28,000 after purchasing an additional 85 shares during the period. Hurley Capital LLC purchased a new stake in shares of Penumbra during the fourth quarter valued at $56,000. Huntington National Bank boosted its stake in shares of Penumbra by 138.7% during the fourth quarter. Huntington National Bank now owns 265 shares of the company's stock valued at $63,000 after purchasing an additional 154 shares during the period. Versant Capital Management Inc boosted its stake in shares of Penumbra by 893.5% during the first quarter. Versant Capital Management Inc now owns 308 shares of the company's stock valued at $82,000 after purchasing an additional 277 shares during the period. Finally, Jones Financial Companies Lllp boosted its stake in shares of Penumbra by 25.0% during the fourth quarter. Jones Financial Companies Lllp now owns 375 shares of the company's stock valued at $89,000 after purchasing an additional 75 shares during the period. 88.88% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Penumbra

In related news, Director Bridget O'rourke sold 100 shares of Penumbra stock in a transaction on Thursday, May 15th. The shares were sold at an average price of $286.15, for a total value of $28,615.00. Following the sale, the director owned 5,423 shares of the company's stock, valued at approximately $1,551,791.45. This trade represents a 1.81% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Maggie Yuen sold 2,000 shares of the firm's stock in a transaction on Friday, May 2nd. The shares were sold at an average price of $299.01, for a total value of $598,020.00. Following the completion of the transaction, the chief financial officer owned 13,957 shares in the company, valued at $4,173,282.57. The trade was a 12.53% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 114,810 shares of company stock worth $31,734,215 over the last 90 days. 5.00% of the stock is owned by insiders.

Penumbra Stock Performance

NYSE:PEN traded down $3.76 during midday trading on Wednesday, hitting $244.04. The company's stock had a trading volume of 497,201 shares, compared to its average volume of 453,581. Penumbra, Inc. has a fifty-two week low of $148.00 and a fifty-two week high of $310.00. The firm's 50 day moving average is $267.17 and its 200-day moving average is $268.32. The company has a debt-to-equity ratio of 0.02, a current ratio of 6.30 and a quick ratio of 3.68. The firm has a market cap of $9.45 billion, a P/E ratio of 230.23, a P/E/G ratio of 2.21 and a beta of 0.47.

Penumbra (NYSE:PEN - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported $0.83 EPS for the quarter, topping analysts' consensus estimates of $0.66 by $0.17. The business had revenue of $324.14 million for the quarter, compared to analysts' expectations of $315.72 million. Penumbra had a net margin of 3.41% and a return on equity of 11.14%. The business's revenue was up 16.3% on a year-over-year basis. During the same quarter last year, the company earned $0.41 EPS. Equities analysts anticipate that Penumbra, Inc. will post 3.67 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the stock. Bank of America began coverage on shares of Penumbra in a research note on Friday, March 14th. They set a "buy" rating and a $320.00 target price for the company. Wells Fargo & Company upped their price objective on shares of Penumbra from $305.00 to $315.00 and gave the stock an "overweight" rating in a research note on Thursday, April 24th. UBS Group reaffirmed a "buy" rating and issued a $330.00 price objective (up from $320.00) on shares of Penumbra in a research note on Thursday, April 24th. Citigroup lowered their price objective on shares of Penumbra from $320.00 to $285.00 and set a "neutral" rating for the company in a research note on Wednesday. Finally, Stifel Nicolaus set a $318.00 price objective on shares of Penumbra and gave the stock a "buy" rating in a research note on Thursday, April 24th. Three analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $305.07.

Penumbra Company Profile

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.